Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Stock
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
-2.18M
-
Total reported value, excl. options
-
$22.7M
-
Value change
-
-$2.16M
-
Put/Call ratio
-
0.01
-
Number of buys
-
20
-
Number of sells
-
-19
-
Price
-
$0.94
Significant Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q3 2023
62 filings reported holding CDTX - CIDARA THERAPEUTICS INC COM NEW - Stock as of Q3 2023.
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
.
Largest 10 shareholders include BVF INC/IL (6.86M shares), VANGUARD GROUP INC (3.29M shares), Nantahala Capital Management, LLC (2.54M shares), ALETHEA CAPITAL MANAGEMENT, LLC (1.63M shares), RENAISSANCE TECHNOLOGIES LLC (1.6M shares), Point72 Asset Management, L.P. (1.25M shares), 5AM Venture Management, LLC (1.13M shares), BlackRock Inc. (943K shares), GEODE CAPITAL MANAGEMENT, LLC (806K shares), and Schonfeld Strategic Advisors LLC (611K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.